ZDHHC11-mediated AXL palmitoylation promotes osimertinib resistance in non-small-cell lung cancer

Journal:
Proceedings of the National Academy of Sciences of the United States of America
Published:
DOI:
10.1073/pnas.2502778122
Affiliations:
4
Authors:
10
Go to article
Institutions Authors Share
Nanjing University of Chinese Medicine (NJUCM), China
4.833333
 0.48
Jiangsu Integrated Chinese and Western Medicine Hospital, China
3.333333
 0.33
Jiangsu Provincial People's Hospital (The First Affiliated Hospital of Nanjing Medical University), China
1.000000
 0.10
State Key Laboratory on Technologies for Chinese Medicine Pharmaceutical Process Control and Intelligent Manufacture, China
0.833333
 0.08
Interested in Oncology and Carcinogenesis?